Zymeworks (ZYME) Payables (2021 - 2026)

Zymeworks has reported Payables for 6 years, with the latest figure at $30.2 million in Q1 2026.

• Quarterly Payables fell 20.92% year-over-year to $30.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.2 million (down 20.92% YoY) and the FY2025 annual result came in at $36.3 million, down 39.26% from the prior year.
• Payables retreated to $30.2 million in Q1 2026 per ZYME's latest filing, from $36.3 million in the prior quarter.
• Over five years, Payables peaked at $87.5 million in Q4 2022 and troughed at $30.2 million in Q1 2026.
• A 5-year average of $50.4 million and a median of $47.4 million in 2024 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2023: Payables surged 39.3% in 2022, then slumped 47.42% in 2023.
• Over 5 years, Payables stood at $87.5 million in 2022, then slumped by 47.42% to $46.0 million in 2023, then jumped by 30.11% to $59.8 million in 2024, then sank by 39.26% to $36.3 million in 2025, then retreated by 16.84% to $30.2 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $30.2 million, $36.3 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.